InvestSMART

XRF Scientific Limited (ASX: XRF) - Announcements

Current share price for XRF : $1.690 0.01 (0.59%)+

ASX company news and announcements for XRF Scientific Limited (XRF) are delayed by 20 minutes from the time of their release between 7.30am and 7.30pm EDT and are in PDF format. All XRF Scientific Limited (XRF) ASX announcements deemed to be price sensitive will be highlighted with . If you are looking for ASX announcements for companies other than XRF Scientific Limited (XRF), please use our Company Announcements tool to search across all ASX-listed companies.

Latest company announcements for XRF Scientific Limited (XRF)

Search all Announcements
Market Cap ($m) Headline Release
date/time+		 Price at
release+		 Current
price+		 Gain/Loss View
$242 Orbis Earnout Payment 22 Aug 2025 4:35PM $2.230 $1.690 fallen by 24.22%
$242 Change of Director's Interest Notice - V. Stazzonelli 22 Aug 2025 3:44PM $2.230 $1.690 fallen by 24.22%
$242 Notification of cessation of securities - XRF 22 Aug 2025 3:42PM $2.230 $1.690 fallen by 24.22%
$242 Application for quotation of securities - XRF 22 Aug 2025 3:38PM $2.240 $1.690 fallen by 24.55%
$242 2025 Appendix 4G & Corporate Governance Statement 19 Aug 2025 9:39AM $2.160 $1.690 fallen by 21.76%
$242 August 2025 Investor Presentation 19 Aug 2025 9:38AM $2.160 $1.690 fallen by 21.76%
$242 Dividend/Distribution - XRF 19 Aug 2025 9:35AM $2.160 $1.690 fallen by 21.76%
$242 XRF announces record full-year result 19 Aug 2025 9:32AM $2.160 $1.690 fallen by 21.76%
$242 Annual Report to shareholders 19 Aug 2025 9:31AM $2.160 $1.690 fallen by 21.76%
$242 Preliminary Final Report 19 Aug 2025 9:29AM $2.160 $1.690 fallen by 21.76%
$242 Change of Director's Interest Notice - V. Stazzonelli 26 May 2025 1:22PM $1.585 $1.690 risen by 6.62%
$242 March 2025 Quarterly Trading Report 15 Apr 2025 9:13AM $1.790 $1.690 fallen by 5.59%
$242 Change of Director's Interest Notice - D. Brown 14 Mar 2025 4:04PM $1.860 $1.690 fallen by 9.14%
$242 Application for quotation of securities - XRF 12 Mar 2025 2:10PM $1.815 $1.690 fallen by 6.89%
$242 S&P DJI Announces March 2025 Quarterly Rebalance 7 Mar 2025 5:01PM $1.930 $1.690 fallen by 12.44%
$242 Change in substantial holding 25 Feb 2025 3:14PM $2.050 $1.690 fallen by 17.56%
$242 February 2025 Investor Presentation 18 Feb 2025 9:51AM $1.895 $1.690 fallen by 10.82%
$242 XRF announces record half-year result 18 Feb 2025 9:50AM $1.895 $1.690 fallen by 10.82%
$242 Appendix 4D - Half-Year Report 18 Feb 2025 9:49AM $1.895 $1.690 fallen by 10.82%
$242 Cleansing Statement 13 Dec 2024 2:42PM $1.775 $1.690 fallen by 4.79%
$242 Application for quotation of securities - XRF 13 Dec 2024 2:40PM $1.775 $1.690 fallen by 4.79%
$242 Completion of Labfit Acquisition 13 Dec 2024 9:40AM $1.810 $1.690 fallen by 6.63%
$242 Proposed issue of securities - XRF 12 Dec 2024 3:44PM $1.800 $1.690 fallen by 6.11%
$242 XRF Acquires Labfit 22 Nov 2024 9:42AM $1.620 $1.690 risen by 4.32%
$242 Change of Director's Interest Notice - V. Stazzonelli 4 Nov 2024 5:35PM $1.610 $1.690 risen by 4.97%

26 - 50 of 373 results

Page 2 of 15

  • + Company announcements and prices are delayed by least 20 minutes. Prices are indicative only.

DISCLOSURE: InvestSMART Group Limited employees may have an interest in the securities and managed funds displayed via this service. Please refer to our Financial Services Guide for more information.

Data shown on this website is sourced by Morningstar
© Morningstar. All rights reserved. Neither any Morningstar company nor any of their content providers guarantee the data or content contained herein to be accurate, complete or timely nor will they have any liability for its use or distribution. Any general advice has been prepared by Morningstar Australasia Pty Ltd (ABN: 95 090 665 544, AFSL: 240892) and/or Morningstar Research Limited, subsidiaries of Morningstar, Inc, without reference to your objectives, financial situation or needs. You should consider the advice in light of these matters and, if applicable, the relevant Product Disclosure Statement (in respect of Australian products) or Investment Statement (in respect of New Zealand products) before making any decision to invest. No Morningstar-affiliated company or any of their employees is providing you with personalised financial advice. To obtain advice tailored to your particular circumstances, please contact a professional financial adviser. Some material is copyright and published under licence from ASX Operations Pty Limited ACN 004 523 782 ("ASXO"). Data and content is provided for personal use only.